UFP Technologies, a key player in the medical device industry, develops and manufactures specialized products. As highlighted by GlobeNewswire, the company plans to release its first-quarter financial results on May 4, 2026. A conference call to discuss these crucial Q1 earnings will follow on May 5, offering further investor insights.
Investors are closely watching for the upcoming earnings report. Wall Street analysts have set an earnings per share (EPS) estimate of $2.18 for UFP Technologies. They also project that the company's revenues will be around $154.78 million for the quarter, a key figure in this stock market analysis.
The company's valuation is reflected in its price-to-earnings (P/E) ratio of 21.89. This crucial valuation metric shows how much investors are paying for each dollar of UFP Technologies' earnings. UFP Technologies also has a price-to-sales ratio of 2.48 and an enterprise value-to-sales ratio of 2.71, providing a comprehensive view of its market standing.
Looking at its overall financial health, UFP Technologies maintains a debt-to-equity ratio of 0.36. This important metric compares the company's total debt to the value owned by shareholders, indicating its reliance on borrowing. The company's earnings yield, a key measure of return for investors, is currently 4.57%.
The company's ability to cover its short-term obligations is shown by its current ratio of 2.68. This suggests that UFP Technologies has $2.68 in current assets for every dollar of its current liabilities, indicating a strong liquidity position and overall financial stability.
